Adrian Daly
About
In The Last Decade
Adrian Daly
141 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Endocrinology, Diabetes and Metabolism 3.3k
- Surgery 1.8k
- Epidemiology 945
- Genetics 754
- Molecular Biology 717
Countries citing papers authored by Adrian Daly
This map shows the geographic impact of Adrian Daly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Daly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Daly more than expected).
Fields of papers citing papers by Adrian Daly
This network shows the impact of papers produced by Adrian Daly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Daly. The network helps show where Adrian Daly may publish in the future.
Co-authorship network of co-authors of Adrian Daly
This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Daly. A scholar is included among the top collaborators of Adrian Daly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Daly. Adrian Daly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | Characterization of GPR101 transcripts structure, expression and signaling | 0 |
| 5 | X-Linked acro-gigantism (X-LAG) syndrome : two new cases with long-term follow-up | 1 |
| 6 | Ary Hydrocarbon receptor interacting protein (AIP) on somatotroph adenomas : a molecular target for somatostatin analogues ? | 1 |
| 7 | Screening for AIP mutations in young patients with pituitary macroadenomas | 1 |
| 8 | Factors associated with AIP expression in somatotropinomas and the possible influence of somatostatin analogues | 0 |
| 9 | An International collaborative study of the Clinical characteristics and Therapeutic Responses in 92 pituitary Adenoma patients with mutations of the Aryl Hydrocarbon Receptor Interacting protein gene | 2 |
| 10 | Learning from recombinant GH treatment in obesity | 1 |
| 11 | High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas | 5 |
| 12 | The Epidemiology of Acromegaly | 30 |
| 13 | Aryl Hydrocarbon Receptor interacting Protein Gene Mutations in Bulgarian FIPA and Young Sporadic Pituitary Adenoma Patients | 7 |
| 14 | Germline AIP, MEN1, PRKAR1A, CDKN1B (p27Kip1) and CDKN2C (p18INK4c) gene mutations in a large cohort of pediatric patients with pituitary adenomas occurring in isolation or with associated syndromic features | 10 |
| 15 | Two Novel Mutations of the Calcium Sensing Receptor gene | 1 |
| 16 | The Epidemiology of pituitary tumors : Results of an international collaborative study | 2 |
| 17 | Characterization of a family harboring a novel LHBéta subunit mutation associated with hypogonadism | 9 |
| 18 | Epidémiologie des adénomes hypophysaires | 1 |
| 19 | A multicenter collaborative study to measure the prevalence of pituitary disease : methodology and preliminary findings | 1 |
| 20 | Acromegaly - Pathology, diagnosis and treatment | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.